福元医药(601089.SH)：盐酸溴己新口服溶液获得药品注册证书

Core Viewpoint - Fuyuan Pharmaceutical (601089.SH) announced that its wholly-owned subsidiary, Anhui Fuyuan, has received a drug registration certificate from the National Medical Products Administration for the production of Bromhexine Hydrochloride Oral Solution [1] Group 1 - The drug approved is Bromhexine Hydrochloride Oral Solution, with a specification of 200ml:160mg [1] - The certificate number for the drug registration is 2026S00394 [1]